Operculina turpethum attenuates N-nitrosodimethylamine induced toxic liver injury and clastogenicity in rats

Chemico-Biological Interactions

Volumn 181, Issue 2, 2009, Pages 145-153

  Ahmad, Riaz ^a   Ahmed, Sarfaraz ^a   Khan, Nizam Uddin ^a   Hasnain, Absar ul ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Clastogenicity; Hepatic fibrosis; LDH isoenzymes; N Nitrosodimethylamine; NDMA; Operculina turpethum; Toxic liver injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DIMETHYLNITROSAMINE; EOSIN; HEMATOXYLIN; HYDROXYPROLINE; LACTATE DEHYDROGENASE; LIVER PROTECTIVE AGENT; OPERCULINA TURPETHUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CELL ACTIVATION; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; CONVOLVULACEAE; DISEASE COURSE; DRUG EFFICACY; HYDROXYPROLINE URINE LEVEL; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER PROTECTION; LIVER REGENERATION; LIVER SIZE; LIVER TOXICITY; MALE; NONHUMAN; OPERCULINA TURPETHUM; PLANT ROOT; RAT; STELLATE CELL;

ACTINS; ANIMALS; BODY WEIGHT; CONVOLVULACEAE; DIMETHYLNITROSAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATITIS, TOXIC; LIVER; MALE; MUSCLE, SMOOTH; MUTAGENS; ORGAN SIZE; PLANT EXTRACTS; RATS; RATS, WISTAR;

ANIMALIA; OPERCULINA TURPETHUM; RATTUS;

EID: 68849094133     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.06.021     Document Type: Article

References (52)

1. George J., Rao K.R., Stern R., and Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 156 (2001) 129-138
2. George J., and Chandrakasan G. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim. Biophys. Acta 1292 (1996) 215-222
3. IARC monographs on the evaluation of carcinogenic risk of chemicals to man, vol. 1 (1971), International Agency for Research on Cancer, World Health Organization, Lyon, France pp. 95-106.
4. Lijinsky W., and Epstein S.S. Nitrosamines as environmental carcinogens. Nature (London) 225 (1970) 21-23
5. Magee P.N., and Barnes J.M. Carcinogenic nitroso compounds. Adv. Cancer. Res. 10 (1967) 163-247
6. Jenkins S.A., Grandison A., Baxter J.N., Day D.W., Taylor I., and Shields R. A dimethylnitrosamine induced model of cirrhosis and portal hypertension in the rat. J. Hepatol. 1 (1985) 489-499
7. Jezequel A.M., Mancini R., Rinaldesi M.L., Macarri G., Venturini C., and Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J. Hepatol. 5 (1987) 174-181
8. Jezequel A.M., Ballardini G., Mancini R., Paolucci F., Bianchi F.B., and Orlandi F. Modulation of extracellular matrix components during dimethylnitrosamine-induced cirrhosis. J. Hepatol. 11 (1990) 206-214
9. George J., and Chandrakasan G. Glycoprotein metabolism in dimethylnitrosamine induced hepatic fibrosis in rats. Int. J. Biochem. Cell Biol. 28 (1996) 353-361
10. George J. Ascorbic acid concentrations in dimethylnitrosamine-induced hepatic fibrosis in rats. Clin. Chim. Acta 335 (2003) 39-47
11. Friedman S.L., and Bansal M.B. Reversal of hepatic fibrosis: fact or fantasy. Hepatology 43 (2006) S82-88
12. Friedman S.L. Liver fibrosis-from bench to bedside. J. Hepatol. 38 (2003) S38-S53
13. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 209-218
14. Pinzani M., and Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver. Dis. 21 (2001) 397-416
15. Lotersztajn S., Julien B., Teixeira-Clerc F., Grenard P., and Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 605-628
16. Kisseleva T., and Brenner D.A. Hepatic stellate cells and the reversal of fibrosis. J. Gastroenterol. Hepatol. 21 Suppl. (2006) S84-87
17. Das S.K., and Vasudevan D.M. Genesis of hepatic fibrosis and its biochemical markers. Scand. J. Clin. Lab. Invest. (2007) 1-10
18. Kang K.W., Kim Y.G., Cho M.K., Bae S.K., Kim C.W., Lee M.G., and Kim S.G. Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation. FASEB J. 16 12 (2002) 1988-1990
19. Austin D.F. Operculina turpethum (Convolvulaceae) as a medicinal plant in Asia. Econ. Bot. 36 (1982) 265-269
20. Newman D.J., Cragg G.M., and Snader K.M. Natural products as sources of new drugs over the period of 1981-2002. J. Nat. Prod. 66 (2003) 1022-1033
21. Colvard M.D., Cordell G.A., Villalobos R., Sancho G., Soejarto D.D., Pestle W., Echeverri T.L., Perkowitz K.M., and Michel J. Survey of medical ethnobotanicals for dental and oral medicine conditions and pathologies. J. Ethnopharmacol. 107 (2006) 134-142
22. Arif J.M., Sawant S.S., El Sayed K.A., Kunhi M., Subramanian M.P., Siddiqui Y.M., Youssef D.T.A., Al-Hussain K.A., Al-Ahdal M.N., and Al-Khodairy F. Antiproliferative potential of sarcophine and its semi synthetic sulfur-containing derivatives against human mammary carcinoma cell lines. J. Nat. Med. 61 (2007) 154-158
23. George J., Suguna L., Jayalakshmi R., and Chandrakasan G. Efficacy of Silymarin and curcumin on dimethyl nitrosamine induced liver fibrosis in rats. Biomedicine 26 (2006) 18-26
24. Agner A.R., Maciel M.A.M., Pinto A.C., and Colus I.M.S. Antigenotoxicity of trans-hydrocrotonin, a clerodane diterpene from Croton cajucara. Planta Med. 67 (2001) 815-819
25. Ames B.N. Dietary carcinogens and anticarcinogens. Science 221 (1983) 256-264
26. Bruni R., Rossi D., Muzzoli M., Romagnoli C., Paganeto G., Besco E., Choquecillo F., Peralta K., Lora W.S., Sacchetti G., and Antimutagenic. antioxidant and antimicrobial properties of Maytenus krukovii bark. Fitoterapia 77 (2006) 538-545
27. Barcelos G.R.M., Shimabukuro F., Mori M.P., Maciel M.A.M., and Colus I.M.S. Evaluation of mutagenicity and antimutagenicity of cashew stem bark methanolic extract in vitro. J. Ethnopharmacol. 114 (2007) 268-273
28. Ahmad R., Khan A.V., Siddiqui M.F., and Hasnain A. Effects of Croton bonplandianum Baill in rats, Environ. Toxicol. Pharmacol. 26 (2008) 336-341
29. The Wealth of India-A Dictionary of Indian Raw Materials and Industrial Products, vol. 7 (2001), CSIR, Delhi
30. Suresh Kumar S.V., Sujatha C., Syamala J., Nagasudha B., and Mishra S.H. Protective effect of root extract of Operculina turpethum Linn. against paracetamol-induced hepatotoxicity in rats. Ind. J. Pharm. Sci. 68 (2006) 32-35
31. Vasudevan N.V. Indian Medicinal Plants vol. IV (1995), Orient Longman Ltd., Chennai 172
32. Harbone J.B. Phytochemical methods-A Guide to Modern Technique of Plant Analysis (1973), Chapman and Hall, London
33. George J., and Chandrakasan G. Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin. Biochem. 33 7 (2000) 563-570
34. Siddiqui M.F., Ahmad R., Ahmad W., and Hasnain A. Micronuclei induction and chromosomal aberrations in Rattus norvegicus by chloroacetic acid and chlorobenzene. Ecotox. Environ. Safety 65 (2006) 159-164
35. Woessner Jr. J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93 (1961) 440-447
36. Ahmad R., and Hasnain A. Ontogenetic changes and developmental adjustments in lactate dehydrogenase isozymes of an obligate air-breathing fish Channa punctatus during deprivation of air access. Comp. Biochem. Physiol. 140B (2005) 271-278
37. Ahmad R., Qayyum S., Hasnain A., Ara A., Khan A.H., and Alam M. Observation on the changes in lactate dehydrogenase isoenzymes in post-burn patients: significance in relation to creatine kinase. J Med. Biochem. 28 (2009) 16-21
38. Savolainen E.R., Brocks D., Ala-Kokko L., and Kivirikko K.I. Serum concentrations of the n-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis. Biochem. J. 249 (1988) 753-757
39. Jenkins S.A., Grandison A., Baxter J.N., Day D.W., Taylor I., and Shields R. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat. J. Hepatol. 1 (1985) 489-499
40. Chowdhury S.A., and Taylor R. Insulin sensitivity in experimental cirrhosis. Mol. Cell. Biochem. 89 (1998) 69-72
41. Lee H.S., Jung K.H., Park I.S., Kwon S.W., Lee D.H., and Hong S.S. Protective effect of Morin on dimethylnitrosamine-induced hepatic fibrosis in rats. Dig. Dis. Sci. 54 (2009) 782-788
42. Brenner D.A., Waterboer T., Choi S.K., Lindquist J.N., Stefanovic B., Burchardt E., Yamauchi M., Gillan A., and Rippe R.A. New aspects of hepatic fibrosis. J. Hepatol. 32 (2000) 32-38
43. George J. Elevated serum β-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats. Biochem. Cell Biol. 86 (2008) 235-243
44. Rockey D.C., Boyles J.K., Gabbiani G., and Friedman S.L. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J. Submicroscopic Cytol. Pathol. 24 (1992) 193-203
45. Anbuselvam C., Vijayavel K., and Balasubramanian M.P. Protective effect of Operculina turpethum against 7,12-dimethyl benz(a)anthracene induced oxidative stress with reference to breast cancer in experimental rats. Chem. Biol. Interact. 168 (2007) 229-236
46. Khare A.K., Srivastava M.C., Tewari J.P., Puri J.N., Singh S., and Ansari N.A. A preliminary study of anti-inflammatory activity of Ipomoea turpethum (Nisoth). Ind. Drugs. 19 (1982) 224-226
47. George J., and Chandrakasan G. Lactate dehydrogenase isoenzymes during dimethylnitrosamine-induced hepatic fibrosis in rats. J. Clin. Biochem. Nutr. 22 (1997) 51-62
48. El-Zayat E.M. Isoenzyme pattern and activity in oxidative stress-induced hepatocarcinogenesis: the protective role of selenium and vitamin E. Res. J. Med. Med. Sci. 2 (2007) 62-71
49. Ahmad R., Alam M., Siddiqui M.F., and Hasnain A. Adjustments of serum lactate dehydrogenase isoenzymes and their significance in monitoring the treatment in patients with tubercular pyothorax. Ind. J. Clin. Biochem. 23 (2008) 181-185
50. Murawaki Y., Yamada S., Koda M., and Hirayama C. Collagenase and collagenolytic cathepsin in normal and fibrotic rat liver. J. Biochem. 108 (1990) 241-244
51. Hall P., De La M., Plummer J.L., Ilsley A.H., and Cousins M.J. Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat. Hepatology 13 (1991) 815-819
52. Murawaki Y., and Hirayama C. Hepatic collagenolytic cathepsin in patients with chronic liver disease. Clin. Chim. Acta 108 (1980) 121-128